After Falling 67% in 1 Year, Is 23andMe Undervalued?
23andMe (NASDAQ: ME) investors have had a bumpy ride in the last 12 months. The company's shares are down by more than 67%, quarterly revenue growth has slumped into the single digits, and profitability remains far out of reach.
Nonetheless, enterprising investors may believe that the company's fortunes will soon be looking up -- a view that management shares. Is this stock priced attractively for a purchase?
Image source: Getty Images.
Source Fool.com
